We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI Technique for Detecting Cancer Could Replace Biopsies

By MedImaging International staff writers
Posted on 06 Apr 2015
Print article
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
A study suggests Magnetic Resonance Imaging (MRI) could be used for the noninvasive detection of cancer cells to complement or replace biopsies, without the need for injection of contrast dyes.

Researchers at Johns Hopkins School of Medicine (Baltimore, MD, USA) tested a technique that detects sugar molecules shed by the outer membranes of cancerous cells, so far only on lab-grown cells and mice.

The results of the study were published on online, in the journal Nature Communications on March 27, 2015.

Xiaolei Song, PhD, the lead author on the study, said, “This is the first time a property integral to cancer cells, rather than an injected dye, has been used to detect those cells. The advantage of detecting a molecule already inside the body is that we can potentially image the entire tumor. This often isn’t possible with injected dyes because they only reach part of the tumor. Plus, the dyes are expensive.

The team will next try to distinguish additional types of cancerous tumors from benign masses in live mice. If they succeed it could lead to earlier detection of cancer, new methods to monitor response to chemotherapy, and new ways to guide biopsies that may eventually make some biopsies unnecessary.

Related Links:

Johns Hopkins School of Medicine


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Portable X-Ray Unit
AJEX240H
Thyroid Shield
Standard Thyroid Shield
PACS Workstation
CHILI Web Viewer

Print article
Radcal

Channels

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.